Golestan Fellowship

About the Golestan Fellowship

The fellowship is funded by a legacy from the late Prof. Dr. Med. Kenower Weimar Bash, a Swiss psychiatrist, who was a NIAS Fellow during the academic year 1973/74. Golestan Fellows are engaged in research in the medical or biological sciences and should already have made a significant contribution to their field of research. They should have a specialisation that makes it profitable to be in daily contact with scholars who carry out advanced research in the humanities and social sciences.

Practical Information

• The Golestan Foundation strives to offer either one 5-month fellowship per year or a 10-month fellowship every other year.
• The fellowship is for preferably non-Dutch scholars carrying out research in the medical or biological sciences.
• Fellows from abroad may apply for a stipend to make up for the loss of income up to a maximum of €3,800 per month.
• Fellows from a Dutch university may apply for financial compensation to cover (part of) the costs to replace their teaching obligations (€2,500 per month).
• The Golestan Fellowship includes an office space, research facilities and communal lunches. For more information, please read the fellowship’s practical details.
• NIAS offers accommodation on top locations against subsidised rates to fellows from abroad. Accommodation is located in Amsterdam.
• If a Fellow is from the Netherlands and lives less than ninety (90) minutes away from the NIAS-KNAW building (one-way, calculated from the train station in his/her home town to Amsterdam Central station), he/she shall receive reimbursement of travel expenses.

Application and Selection

• Golestan Fellowships are available by direct application and by nomination.
• The NIAS directorate can nominate suitable researchers from the regular NIAS fellowship application process, for a Golestan Fellowship.
• The Board of the Golestan Foundation selects the Golestan Fellows in consultation with the Director of NIAS.
• The candidates for a Golestan Fellowship will be informed of the outcome of the selection procedure in early May 2024.